Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness

Nowadays, colon cancer prognosis still difficult to predict, especially in the early stages. Recurrences remain elevated, even in the early stages after curative surgery. Carcidiag Biotechnologies has developed an immunohistochemistry (IHC) kit called ColoSTEM Dx, based on a MIX of biotinylated plan...

Descripción completa

Detalles Bibliográficos
Autores principales: Blondy, Sabrina, Durand, Stéphanie, Lacroix, Aurélie, Christou, Niki, Bouchaud, Charline, Peyny, Maud, Battu, Serge, Chauvanel, Alain, Carré, Vincent, Jauberteau, Marie-Odile, Lalloué, Fabrice, Mathonnet, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355573/
https://www.ncbi.nlm.nih.gov/pubmed/35936672
http://dx.doi.org/10.3389/fonc.2022.918702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355573/
https://www.ncbi.nlm.nih.gov/pubmed/35936672
http://dx.doi.org/10.3389/fonc.2022.918702

Ejemplares similares